QTRACE® Analysis System Attains CE Mark
/JETA Molecular is pleased to announce that earlier this year, we filed a Declaration of Conformity to CE IVD-D standards for our flagship chimerism product, the QTRACE® Analysis System.
Read MoreJETA Molecular is pleased to announce that earlier this year, we filed a Declaration of Conformity to CE IVD-D standards for our flagship chimerism product, the QTRACE® Analysis System.
Read MoreAt JETA Molecular, we make every effort to offer our customers unique and innovative products employing creative solutions for transplant monitoring. The MultiTRACE™ Genotyping Plate, our newest product, takes advantage of multiplex quantitative PCR that enables to detect multiple targets in a single reaction.
Read MoreToday we celebrate with our extended family of customers, collaborators, vendors, consultants, sales partners, and many others... THANK YOU!
Read MoreJETA Molecular is proud to introduce the Extended Panel of QTRACE® INDEL Assays with 34 additional markers designed for use in chimerism monitoring. This will significantly facilitate the choice of informative assays for chimerism monitoring and improve the follow-up of HSCT patients.
With a total number of 80 INDEL Assays, QTRACE® represents the broadest set of markers currently available on the market.
Read MoreThe organizers of EFI 2020 have decided to postpone the conference due to the current coronavirus pandemic. The new dates announced are Thursday 22nd April - Sunday 25th April 2021.
JETA Molecular has submitted two abstracts that have been selected for a poster presentation. One of the abstracts describes the analytical validation of dPCR assays for monitoring of chimerism, the other one focuses on the timely detection of HLA LOH relapses.
+31 654 136 697 ⎜ info@jetabv.com
Krommewetering 101C, Utrecht, 3543AN, The Netherlands
Copyright © JETA Molecular BV.
All Rights Reserved │Privacy Policy